fda decision: gedatolisib by celcuity inc. (on 2026-01-01)
Conditional / Accelerated Approval
fda decision: gedatolisib by celcuity inc. (on 2026-01-01). Best Yes near 11¢ across 1 platform. Live cross-platform prices. Not financial advice.
Best Yes: 11¢ · Best No: 96¢ · 1 platform
- Kalshi: Yes 11¢ / No 96¢
LIVE
Conditional / Accelerated Approval
Volume
$0
$0 24h
Platforms
1
Cross-platform pricing
Resolution
Resolves Aug 1, 2026
~46 days left
Category
Economics
Yes
11¢
Kalshi
No
96¢
Kalshi
Opens on best-price platform
Compare & Trade
1 platform
Price History
Loading…
About This Market
If the FDA's decision on Gedatolisib by Celcuity Inc. in July 2026 is Conditional / Accelerated Approval before Aug 1, 2026, the market resolves to Yes.
Market Details
ResolutionResolves Aug 1, 2026
Time Left46 days
Status● Active
CategoryEconomics
Yes
11¢
Kalshi
Payout 9.1x
No
96¢
Kalshi
Payout 1.0x
Opens on best-price platform
Compare & Trade
1 platformSign in to join the discussion
Sign In